4 free views remaining today

malignant secondary hypertension

ICD-10 Codes

Related ICD-10:

Description

Signs and Symptoms

Malignant Secondary Hypertension Signs and Symptoms

Malignant secondary hypertension, also known as accelerated hypertension, is a severe form of high blood pressure that can cause damage to organs and tissues if left untreated. The signs and symptoms of this condition can vary depending on the underlying cause, but here are some common indicators:

  • Sudden increase in blood pressure: A rapid spike in blood pressure can be a sign of malignant secondary hypertension.
  • Blurred vision: High blood pressure can cause changes in vision, including blurred vision or even loss of vision.
  • Changes in mental status: People with malignant secondary hypertension may experience anxiety, confusion, decreased alertness, decreased ability to concentrate, fatigue, and other cognitive impairments.
  • Chest pain: Chest pain or discomfort can be a symptom of this condition, especially if it's accompanied by shortness of breath or difficulty breathing.
  • Nausea or vomiting: Some people may experience nausea or vomiting due to the sudden increase in blood pressure.
  • Numbness or weakness: Malignant secondary hypertension can cause numbness or weakness in the face, arm, or leg on one side of the body.
  • Swelling in the lower legs and feet: Fluid buildup in the lower extremities can be a sign of this condition.
  • Abnormal heart sounds and fluid in the lungs: A physical exam may reveal abnormal heart sounds or fluid accumulation in the lungs.

Underlying Causes

Malignant secondary hypertension is often caused by underlying conditions such as:

  • Adrenal disorders (e.g., Conn's syndrome, Cushing's syndrome)
  • Central nervous system disorders (e.g., brain bleed, stroke, traumatic brain injury)
  • Kidney disease or heart condition
  • Pheochromocytoma or a renin-secreting tumor

Medical Emergency

Malignant secondary hypertension is considered a medical emergency and requires immediate attention. If you or someone you know is experiencing any of these symptoms, seek medical help right away.

References:

[3] Malignant hypertension is a medical emergency. A physical exam commonly shows: Extremely high blood pressure; Swelling in the lower legs and feet; Abnormal heart sounds and fluid in the lungs; Changes in thinking, sensation, and reflexes ; An eye exam may reveal changes that indicate very high blood pressure, including: [3]

[6] Malignant hypertension (MHT) is a severe form of high blood pressure.It is characterized by a sudden spike in blood pressure and acute organ damage. The incidence of MHT in the United States is highest among Black Americans, current and former smokers, and people with a history of renal artery stenosis (narrowing in one or more arteries carrying blood to the kidneys). [6]

[9] What are the symptoms of a hypertensive emergency? · changes in vision, including blurred vision · chest pain · confusion · nausea or vomiting · numbness or weakness ... [9]

[12] High blood pressure has secondary causes, such as kidney disease or heart condition. ... Malignant hypertension can be both essential and secondary. Symptoms. Malignant hypertension is the most severe variation of high blood pressure. Organs generally affected by this condition are kidneys, heart, brain, and eyes. ... At the first signs of ... [12]

Diagnostic Tests

Diagnostic Tests for Malignant Secondary Hypertension

Malignant secondary hypertension is a severe and potentially life-threatening condition that requires prompt diagnosis and treatment. The following diagnostic tests can help identify the underlying cause of malignant hypertension:

  • Urinalysis: A urine test (urinalysis) can detect markers that indicate medical conditions causing high blood pressure, such as kidney disease or diabetes [8].
  • Kidney Ultrasound: An ultrasound of the kidneys can reveal structural abnormalities or damage to the kidneys, which may be contributing to secondary hypertension [14].
  • Electrolytes, Urea, Creatinine, and Aldosterone:Renin Ratio: Laboratory tests that measure electrolyte levels, kidney function, and hormone imbalances can help identify underlying causes of malignant hypertension [5].
  • Arterial Blood Gas Analysis, BUN (Blood Urea Nitrogen), Creatinine, and Urinalysis: These tests can provide information on the severity of kidney damage and other potential causes of secondary hypertension [3][6][10].

Additional Tests

Depending on the patient's symptoms and medical history, additional tests may be necessary to diagnose malignant secondary hypertension. These may include:

  • Chest X-ray: To detect signs of fluid retention in the lungs (pulmonary edema) [12].
  • Obstructive Sleep Apnea Testing: A standard diagnostic test for obstructive sleep apnea, which can cause secondary hypertension [13].

Early Detection and Treatment

Prompt diagnosis and treatment are crucial in managing malignant secondary hypertension. Early detection of underlying causes can help prevent further complications and improve patient outcomes.

References:

[3] - Context 5 [5] - Context 5 [6] - Context 6 [8] - Context 8 [10] - Context 10 [12] - Context 12 [13] - Context 13 [14] - Context 14

Treatment

Treatment Options for Malignant Secondary Hypertension

Malignant secondary hypertension, also known as malignant hypertension, is a severe and potentially life-threatening form of high blood pressure that requires immediate medical attention. The treatment for malignant secondary hypertension involves medications to lower blood pressure and address the underlying cause.

  • Intravenous Medications: Intravenous nitroglycerin, clevidipine, or nitroprusside are commonly used to rapidly lower blood pressure in emergency situations [2].
  • Calcium Channel Blockers (CCBs): CCBs, such as vasodilators, may be used as a first-line treatment option for malignant hypertension [4].
  • Renin-Angiotensin System (RAS) Blockers: RAS blockers, diuretics, and other medications are often used to lower blood pressure in patients with malignant secondary hypertension [3].
  • Beta-Blockers: Beta-blockers may be used in conjunction with other medications to control blood pressure, but their use should be avoided before administering vasodilators [7].

Importance of Early Treatment

Early treatment is crucial in managing malignant secondary hypertension. Delaying treatment can lead to severe complications, including kidney damage, heart failure, and even death.

  • Aggressive Blood Pressure Control: Aggressive blood pressure control is essential in reducing the risk of complications associated with malignant secondary hypertension [1].
  • Multidisciplinary Care: A multidisciplinary care team, including cardiologists, nephrologists, and other healthcare professionals, should be involved in managing patients with malignant secondary hypertension to ensure optimal outcomes.

References

[1] This form of malignant hypertension requires care that starts in an emergency room. Therapy includes special medications to lower your blood pressure. You receive these drugs through a vein (intravenously). This phase of treatment may last up to two days. [1] [2] The drugs of choice in treating a hypertensive emergency with acute pulmonary edema are intravenous nitroglycerin, clevidipine, or nitroprusside. [2] [3] RAS blockers, CCBs, and diuretics are first-line drugs. • Lipid-lowering treatment is mandatory with a LDL-C target <70 mg/dL ( ... [3] [4] Jun 4, 2024 — Thus, the optimal treatment may include a vasodilator (most often a calcium channel blocker). Alternatively, use of a beta-blocker will not ... [4] [5] The current consensus for treatment involves early intravenous infusion of antihypertensive agents, but oral blockers of the renin–angiotensin system may ... [5] [7] Aug 27, 2024 — Diazepam, phentolamine, and nitroglycerin/nitroprusside are the preferred drugs. However, avoid beta-adrenergic antagonists before administering ... [7]

Note: The references provided are based on the search results and may not be an exhaustive list of all relevant studies or guidelines.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Malignant secondary hypertension is a type of high blood pressure that can cause acute tissue injury in multiple organs. The differential diagnosis for this condition involves identifying the underlying causes, which can be complex and multifaceted.

According to various medical sources [3][7][10], the differential diagnosis of malignant secondary hypertension includes:

  • Chronic kidney disease
  • Autosomal dominant polycystic kidney disease
  • Renal artery stenosis
  • Fibromuscular dysplasia
  • Primary aldosteronism
  • Cushing syndrome/disease
  • Hyperthyroidism
  • Hypothyroidism
  • Hyperparathyroidism
  • Pheochromocytoma
  • Acromegaly

These conditions can disrupt and complicate the differential diagnosis of malignant secondary hypertension [10]. It's essential to consider these potential causes when evaluating patients with severe hypertension.

In addition, the presence of severe hypertensive retinopathy can trigger a diagnosis of malignant hypertension [13]. However, it's crucial to note that this is not always mandatory, especially in cases where heart, kidney, brain damage, and/or thrombotic microangiopathy are present.

The initial investigation of secondary hypertension typically involves laboratory tests, as shown in Table 1 [14]. Identifying and treating the underlying cause can potentially cure or markedly improve hypertension and reduce associated cardiovascular risk.

References: [3] - Context result 2 [7] - Context result 7 [10] - Context result 10 [13] - Context result 13 [14] - Context result 14

Additional Information

rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_11130
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_8634
22-rdf-syntax-ns#first
t408415
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:13731
core#notation
DOID:13731
oboInOwl#hasDbXref
UMLS_CUI:C0155617
rdf-schema#label
malignant secondary hypertension
relatedICD
http://example.org/icd10/I15.8
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.